Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/03/2014CA2606515C Method of improving learning and memory in mammals
06/03/2014CA2604454C Artificial cerebrospinal fluid
06/03/2014CA2595617C Formulations for injection of catecholic butanes, including ndga compounds, into animals
06/03/2014CA2595496C Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof
06/03/2014CA2590110C Kinase modulators and method of use
06/03/2014CA2588056C 2,3,4-substituted cyclopentanones as therapeutic agents
06/03/2014CA2587183C Andrographolide derivatives to treat viral infections
06/03/2014CA2586701C Lna oligonucleotides and the treatment of cancer
06/03/2014CA2578225C Testosterone gels comprising propylene glycol as penetration enhancer
06/03/2014CA2568804C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
06/03/2014CA2563063C Purification of progesterone receptor modulators
06/03/2014CA2532833C Use of whey permeate for the treatment of metabolic syndrome
06/03/2014CA2529142C Rna interferases and methods of use thereof
06/03/2014CA2497913C Use of chimeric nucleases to stimulate gene targeting
06/03/2014CA2496795C Compositions and methods for treating cardiovascular disease
06/03/2014CA2486716C Compositions and their uses for alleviating pain
06/03/2014CA2443995C Endothelial cell expression patterns
06/03/2014CA2432523C Compositions of stable t3 and methods of use thereof
06/03/2014CA2426942C 8-carboxamido-2,6-methano-3-benzazocines
06/03/2014CA2412764C Stimulation of cellular regeneration and differentiation in the inner ear
05/2014
05/30/2014WO2014082085A1 Use of itk inhibitors for the treatment of cancer
05/30/2014WO2014082027A2 Antioxidant dietary supplement and related method
05/30/2014WO2014081996A1 Novel compounds as diacylglycerol acyltransferase inhibitors
05/30/2014WO2014081995A1 Novel compounds as diacylglycerol acyltransferase inhibitors
05/30/2014WO2014081994A1 Novel compounds as diacylglycerol acyltransferase inhibitors
05/30/2014WO2014081977A1 Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy
05/30/2014WO2014081953A1 Methods and compositions useful for treating diseases involving bcl-2 family proteins with isoquinoline and quinoline derivatives
05/30/2014WO2014081941A1 Methods and compositions for locally increasing body fat
05/30/2014WO2014081925A1 Glutamase inhibitors and method of use
05/30/2014WO2014081887A1 Improved method for the preparation of liposome encapsulated vincristine for therapeutic use
05/30/2014WO2014081886A1 Macrocyclic broad spectrum antibiotics
05/30/2014WO2014081816A1 Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
05/30/2014WO2014081756A1 S1p and/or atx modulating agents
05/30/2014WO2014081752A1 S1p and/or atx modulating agents
05/30/2014WO2014081732A1 Azaindole derivatives as jak3 inhibitors
05/30/2014WO2014081714A2 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/30/2014WO2014081712A2 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/30/2014WO2014081709A2 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/30/2014WO2014081697A2 Anthelmintic compounds and compositions and method of using thereof
05/30/2014WO2014081689A1 Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
05/30/2014WO2014081675A1 Methods and compositions for treating neurodegenerative diseases
05/30/2014WO2014081674A1 Topical dapsone and dapsone/adapalene compositions and methods for use thereof
05/30/2014WO2014081645A1 Novel compounds
05/30/2014WO2014081644A1 Novel compounds
05/30/2014WO2014081643A1 Novel compounds
05/30/2014WO2014081618A1 Thrombin inhibitors
05/30/2014WO2014081617A1 Substituted pyridone derivatives as pde10 inhibitors
05/30/2014WO2014081616A1 Preparation of precursors for leukotriene antagonists
05/30/2014WO2014081581A2 Highly loaded amorphous efavirenz composition and process for preparing the same
05/30/2014WO2014081507A1 Terminally modified rna
05/30/2014WO2014081443A1 Caspofungin acetate formulations
05/30/2014WO2014081405A2 Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dibromodulcitol
05/30/2014WO2014081392A1 Composition and method for respiratory delivery of dye for visualisation of eye
05/30/2014WO2014081391A1 New photoactive bioadhesive compositions
05/30/2014WO2014081340A1 Inhalation composition in the form of an aerosol for the treatment of bronchial asthma and chronic obstructive pulmonary disease
05/30/2014WO2014081338A1 Medicinal agent in the form of an orodispersible tablet and method for producing same
05/30/2014WO2014081325A1 Quinolyl hydrazones for the treatment of tuberculosis and related diseases
05/30/2014WO2014081324A1 Pyridyl hydrazones for the treatment of tuberculosis and related diseases
05/30/2014WO2014081220A1 Amylase-activity-inhibiting composition containing chito-oligosaccharide
05/30/2014WO2014081172A1 Effervescent super-disintegrating imatinib preparation and production method for same
05/30/2014WO2014081157A1 Novel tetrahydropyridinol derivative compound, and pharmaceutical composition comprising same as active ingredient for preventing or treating cancer
05/30/2014WO2014081124A1 Composition for treating or alleviating dental pulp diseases, containing butein as active ingredient
05/30/2014WO2014081029A1 Prophylactic, therapeutic or alleviating agent for peripheral nerve disorders caused by anti-cancer agents
05/30/2014WO2014081025A1 Novel crystal form of 3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)-5-(3-oxo-[1,2]oxazinan-2-ylmethyl)benzamide
05/30/2014WO2014080997A1 Anti-midkine aptamer and applications thereof
05/30/2014WO2014080983A1 Sugar chain-modified trimer structure oligonucleotide and use thereof
05/30/2014WO2014080973A1 Antidementia and learning/memory function-improving drug
05/30/2014WO2014080866A1 Novel human antibody against il-18
05/30/2014WO2014080784A1 Aqueous olanzapine pharmaceutical preparation of having longterm stability
05/30/2014WO2014080703A1 Modified galectin-9 protein
05/30/2014WO2014080640A1 Erythropoietin expression promoter
05/30/2014WO2014080633A1 Polymorph forms
05/30/2014WO2014080413A1 A process for the preparation of acebrophylline
05/30/2014WO2014080384A1 Pharmaceutical composition of linagliptin
05/30/2014WO2014080383A1 Pharmaceutical composition of dipeptidyl peptidase-iv (dpp-iv) inhibitors in combination with other antidiabetics
05/30/2014WO2014080378A1 Phenothiazine derivatives and their use against tuberculosis
05/30/2014WO2014080365A1 Method of reducing an unpleasant odor of a pharmaceutical composition
05/30/2014WO2014080342A1 Industrial process for the synthesis of pyrimidinyl-piperazine derivatives
05/30/2014WO2014080285A2 Pharmaceutical compositions having improved storage stability
05/30/2014WO2014080283A2 Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt
05/30/2014WO2014080282A2 One-and two-point titration methods to determine daily treatment regimens to treat hypogonadism or male testosterone deficiency with an intranasal testosterone bio-adhesive gel, and primary and secondary efficacy and safety endpoints
05/30/2014WO2014080259A1 Novel polymorphic forms of alcaftadine
05/30/2014WO2014080251A1 Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
05/30/2014WO2014080241A1 Imidazopyridine compounds and uses thereof
05/30/2014WO2014080051A1 Use of l-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars
05/30/2014WO2014080004A1 Compositions and methods for modulation of fgfr3 expression
05/30/2014WO2014079995A2 Novel inhibitor compounds of phosphodiesterase type 10a
05/30/2014WO2014079937A1 Pesticidal compounds based on arylthiosulfonamide derivatives
05/30/2014WO2014079922A1 Composition for immediate and extended release
05/30/2014WO2014079903A1 Phosphonucleosides useful in the treatment of viral disorders
05/30/2014WO2014079868A1 Saquinavir-no for immunomodulation
05/30/2014WO2014079850A1 Substituted heterocyclic derivatives
05/30/2014WO2014079840A1 Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
05/30/2014WO2014079806A1 Pyrimidine compounds for treating hairloss
05/30/2014WO2014079805A1 Pyrazole compounds for treating hairloss
05/30/2014WO2014079803A1 Bicyclosubstituted pyrazole compounds for treating hairloss
05/30/2014WO2014079787A1 Substituted 1,6-naphthyridines
05/30/2014WO2014079709A1 Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections
05/30/2014WO2014079573A1 Multi-day patch for the transdermal administration of rotigotine
05/30/2014WO2014079545A1 Thioether derivatives as protein kinase inhibitors
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 7860